Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Cartesian Therapeutics Inc

RNAC
18,06
0,15 (0,84%)
11 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202513:05GLOBECartesian Therapeutics Announces New Employment Inducement..
03/3/202512:59EDGAR2Form 8-K - Current report
18/2/202513:00GLOBECartesian Therapeutics to Participate in Upcoming Investor..
06/2/202513:05GLOBECartesian Therapeutics Announces New Employment Inducement..
27/1/202513:04EDGAR2Form 8-K - Current report
27/1/202513:00GLOBECartesian Therapeutics Announces FDA Special Protocol..
14/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
13/1/202522:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:00GLOBECartesian Therapeutics Highlights Progress and 2025..
10/1/202512:01EDGAR2Form POS AM - Post-Effective amendments for registration..
10/1/202512:00EDGAR2Form POS AM - Post-Effective amendments for registration..
08/1/202522:38EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
08/1/202522:33EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
08/1/202522:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/1/202502:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202502:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202513:05GLOBECartesian Therapeutics Announces New Employment Inducement..
06/1/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202413:05GLOBECartesian Therapeutics Announces New Employment Inducement..
13/12/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
13/12/202422:11EDGAR2Form S-3 - Registration statement under Securities Act of..
13/12/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
11/12/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:21EDGAR2Form 144 - Report of proposed sale of securities
09/12/202422:36EDGAR2Form 144 - Report of proposed sale of securities
03/12/202412:03EDGAR2Form 8-K - Current report
03/12/202412:00GLOBECartesian Therapeutics Announces Positive Updated Results..
22/11/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202422:45EDGAR2Form 144 - Report of proposed sale of securities
21/11/202413:00GLOBECartesian Therapeutics to Present Updated Data from Phase 2b..
20/11/202422:57EDGAR2Form 144 - Report of proposed sale of securities
19/11/202422:36EDGAR2Form 144 - Report of proposed sale of securities
19/11/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 17,92 Min: 17,08 Max: 18,80
Chiusura: 17,91

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network